FDA — authorised 28 August 1978
- Application: ANDA084100
- Marketing authorisation holder: LILLY
- Local brand name: CRYSTODIGIN
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Digicor on 28 August 1978
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 28 August 1978; FDA has authorised it.
LILLY holds the US marketing authorisation.